Long-term Ro60 humoral autoimmunity in primary Sjögren's syndrome is maintained by rapid clonal turnover

Clinical Immunology

Volumn 148, Issue 1, 2013, Pages 27-34

  Lindop, Rhianna ^a   Arentz, Georgia ^a   Bastian, Isabell ^a   Whyte, Andrew F ^a   Thurgood, Lauren A ^a   Chataway, Tim K ^b   Jackson, Michael W ^a   Gordon, Tom P ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

Autoantibodies; Humoral autoimmunity; Mass spectrometry; Primary Sj gren's syndrome; Ro60

Indexed keywords

AUTOANTIBODY; RIBONUCLEOPROTEIN; RIBONUCLEOPROTEIN 60; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNITY; CASE REPORT; HEAVY CHAIN; HUMAN; HUMORAL IMMUNITY; IMMUNOASSAY; LIGHT CHAIN; MASS SPECTROMETRY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SJOEGREN SYNDROME;

ADULT; AGED; AUTOANTIGENS; AUTOIMMUNITY; CLONE CELLS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MASS SPECTROMETRY; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RIBONUCLEOPROTEINS; RNA, SMALL CYTOPLASMIC; SEQUENCE ANALYSIS, PROTEIN; SJOGREN'S SYNDROME;

EID: 84877352276     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2013.03.015     Document Type: Article

References (24)

1. Tan E.M. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 1989, 44:93-151.
2. Harley J.B., Scofield R.H. Systemic lupus erythematosus: RNA-protein autoantigens, models of disease heterogeneity, and theories of etiology. J. Clin. Immunol. 1991, 11:297-316.
3. Heinlen L.D., McClain M.T., Ritterhouse L.L., Bruner B.F., Edgerton C.C., Keith M.P., James J.A., Harley J.B. 60kD Ro and nRNP A frequently initiate human lupus autoimmunity. PLoS One 2010, 5:e9599.
4. Buyon J.P., Clancy R.M. Maternal autoantibodies and congenital heart block: mediators, markers, and therapeutic approach. Semin. Arthritis Rheum. 2003, 33:140-154.
5. Reed J.H., Jackson M.W., Gordon T.P. A B cell apotope of Ro 60 in systemic lupus erythematosus. Arthritis Rheum. 2008, 58:1125-1129.
6. Reed J.H., Clancy R.M., Purcell A.W., Kim M.Y., Gordon T.P., Buyon J.P. Beta2-glycoprotein I and protection from anti-SSA/Ro60-associated cardiac manifestations of neonatal lupus. J. Immunol. 2011, 187:520-526.
7. Pisetsky D.S. Antinuclear antibodies in rheumatic disease: a proposal for a function-based classification. Scand. J. Immunol. 2012, 76:223-228.
8. Derksen R.H., Meilof J.F. Anti-Ro/SS-A and anti-La/SS-B autoantibody levels in relation to systemic lupus erythematosus disease activity and congenital heart block. A longitudinal study comprising two consecutive pregnancies in a patient with systemic lupus erythematosus. Arthritis Rheum. 1992, 35:953-959.
9. Hoyer B.F., Moser K., Hauser A.E., Peddinghaus A., Voigt C., Eilat D., et al. Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice. J. Exp. Med. 2004, 199:1577-1584.
10. Radbruch A., Muehlinghaus G., Luger E.O., Inamine A., Smith K.G., Dorner T., Hiepe F. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat. Rev. Immunol. 2006, 6:741-750.
11. Lindop R., Arentz G., Chataway T.K., Thurgood L.A., Jackson M.W., Reed J.H., McCluskey J., Gordon T.P. Molecular signature of a public clonotypic autoantibody in primary Sjogren's syndrome: a "forbidden" clone in systemic autoimmunity. Arthritis Rheum. 2011, 63:3477-3486.
12. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., Daniels T.E., Fox P.C., Fox R.I., Kassan S.S., Pillemer S.R., Talal N., Weisman M.H. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 2002, 61:554-558.
13. Sedgwick A.K., Ballow M., Sparks K., Tilton R.C. Rapid quantitative microenzyme-linked immunosorbent assay for tetanus antibodies. J. Clin. Microbiol. 1983, 18:104-109.
14. Arentz G., Thurgood L.A., Lindop R., Chataway T.K., Gordon T.P. Secreted human Ro52 autoantibody proteomes express a restricted set of public clonotypes. J. Autoimmun. 2012, 39:466-470.
15. Isaksen K., Jonsson R., Omdal R. Anti-CD20 treatment in primary Sjogren's syndrome. Scand. J. Immunol. 2008, 68:554-564.
16. Liu Z., Zou Y., Davidson A. Plasma cells in systemic lupus erythematosus: the long and short of it all. Eur. J. Immunol. 2011, 41:588-591.
17. Sweet R.A., Ols M.L., Cullen J.L., Milam A.V., Yagita H., Shlomchik M.J. Facultative role for T cells in extrafollicular Toll-like receptor-dependent autoreactive B-cell responses in vivo. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:7932-7937.
18. Reed J.H., Dudek N.L., Osborne S.E., Kaufman K.M., Jackson M.W., Purcell A.W., Gordon T.P. Reactivity with dichotomous determinants of Ro 60 stratifies autoantibody responses in lupus and primary Sjogren's syndrome. Arthritis Rheum. 2010, 62:1448-1456.
19. Lindop R., Arentz G., Thurgood L.A., Reed J.H., Jackson M.W., Gordon T.P. Pathogenicity and proteomic signatures of autoantibodies to Ro and La. Immunol. Cell Biol. 2012, 90:304-309.
20. Chan O.T., Madaio M.P., Shlomchik M.J. The central and multiple roles of B cells in lupus pathogenesis. Immunol. Rev. 1999, 169:107-121.
21. Salinas G.F., Braza F., Brouard S., Tak P.P., Baeten D. The role of B lymphocytes in the progression from autoimmunity to autoimmune disease. Clin. Immunol. 2013, 146:34-45.
22. Yao Y., Liu Z., Jallal B., Shen N., Ronnblom L. Type I interferons in Sjogren's syndrome. Autoimmun. Rev. 2013, 12:558-566.
23. Dorner T., Jacobi A.M., Lee J., Lipsky P.E. Abnormalities of B cell subsets in patients with systemic lupus erythematosus. J. Immunol. Methods 2011, 363:187-197.
24. Crowley J.E., Stadanlick J.E., Cambier J.C., Cancro M.P. FcgammaRIIB signals inhibit BLyS signaling and BCR-mediated BLyS receptor up-regulation. Blood 2009, 113:1464-1473.